Cargando…

Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression()()

Cross talk of stromal-epithelial cells plays an essential role in both normal development and tumor initiation and progression. Fibroblast growth factor (FGF)-FGF receptor (FGFR)-Src kinase axis is one of the major signal transduction pathways to mediate this cross talk. Numerous genomic studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qianjin, Ingram, Lishann, Kim, Sungjin, Beharry, Zanna, Cooper, Jonathan A., Cai, Houjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2018
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814375/ https://www.ncbi.nlm.nih.gov/pubmed/29444487 http://dx.doi.org/10.1016/j.neo.2018.01.006

Ejemplares similares

Long chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation
por: Ma, Yongjie, et al.
Publicado: (2021)

Paracrine interactions through FGFR1 and FGFR2 receptors regulate the development of preimplantation mouse chimaeric embryo
por: Krawczyk, Katarzyna, et al.
Publicado: (2022)

Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations
por: Lima, Nadia Carvalho, et al.
Publicado: (2020)

The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
por: Marhäll, Alissa, et al.
Publicado: (2017)

Progesterone prevents HGSOC by promoting precancerous cell pyroptosis via inducing fibroblast paracrine
por: Wu, Nayiyuan, et al.
Publicado: (2023)

CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
por: Lu, Yongning, et al.
Publicado: (2019)

Encapsulating Cas9 into extracellular vesicles by protein myristoylation
por: Whitley, Joseph Andrew, et al.
Publicado: (2022)

c‐Cbl Is Inducibly Tyrosine‐phosphorylated by Epidermal Growth Factor Stimulation in Fibroblasts, and Constitutively Tyrosine‐phosphorylated and Associated with v‐Src in v‐src‐transformed Fibroblasts
por: Odai, Hideharu, et al.
Publicado: (1995)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2020)

Src is essential for the endosomal delivery of the FGFR4 signaling complex in hepatocellular carcinoma
por: Shin, Ji-Yon, et al.
Publicado: (2021)

Potentiation of Epidermal Growth Factor-Mediated Oncogenic Transformation by Sialidase NEU3 Leading to Src Activation
por: Yamamoto, Koji, et al.
Publicado: (2015)

Oncogenic FGFR3 gene fusions in bladder cancer
por: Williams, Sarah V., et al.
Publicado: (2013)

Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
por: Zhang, Jinglin, et al.
Publicado: (2019)

Functional Screen of Paracrine Signals in Breast Carcinoma Fibroblasts
por: Su, Gui, et al.
Publicado: (2012)

Historical retrospective of the SRC oncogene and new perspectives (Review)
por: Simatou, Aristofania, et al.
Publicado: (2020)

FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib
por: Ying, Xihui, et al.
Publicado: (2019)

Initial Segment Differentiation Begins During a Critical Window and Is Dependent upon Lumicrine Factors and SRC Proto-Oncogene (SRC) in the Mouse
por: Xu, Bingfang, et al.
Publicado: (2016)

AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES : II. MAMMALIAN FIBROBLAST CULTURES TRANSFORMED BY DNA AND RNA TUMOR VIRUSES
por: Ossowski, L., et al.
Publicado: (1973)

Fibroblast Growth Factor Receptor Two (FGFR2) Regulates Uterine Epithelial Integrity and Fertility in Mice
por: Filant, Justyna, et al.
Publicado: (2014)

Src Cooperates with Oncogenic Ras in Tumourigenesis via the JNK and PI3K Pathways in Drosophila epithelial Tissue
por: Poon, Carole L.C., et al.
Publicado: (2018)

Correction: Functional Screen of Paracrine Signals in Breast Carcinoma Fibroblasts
por: Su, Gui, et al.
Publicado: (2013)

Expression of a protein tyrosine phosphatase in normal and v-src- transformed mouse 3T3 fibroblasts
Publicado: (1992)

The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants
por: Chung, Byung Min, et al.
Publicado: (2009)

FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
por: Hong, Chen, et al.
Publicado: (2022)

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
por: Yu, Y, et al.
Publicado: (2014)

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling
por: Goulet, Cassandra Ringuette, et al.
Publicado: (2019)

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling
por: Giordano, Marco, et al.
Publicado: (2021)

AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES : I. CHICK EMBRYO FIBROBLAST CULTURES TRANSFORMED BY AVIAN RNA TUMOR VIRUSES
por: Unkeless, J. C., et al.
Publicado: (1973)

EPS8 phosphorylation by Src modulates its oncogenic functions
por: Shahoumi, Linah A., et al.
Publicado: (2020)

MSH3-Deficiency Initiates EMAST without Oncogenic Transformation of Human Colon Epithelial Cells
por: Campregher, Christoph, et al.
Publicado: (2012)

FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium
por: Best, Sarah A., et al.
Publicado: (2018)

The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives
por: Santolla, Maria Francesca, et al.
Publicado: (2020)

Identification of a novel oncogenic mutation of FGFR4 in gastric cancer
por: Futami, Takashi, et al.
Publicado: (2019)

Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling
por: Nita, Alexandru, et al.
Publicado: (2021)

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
por: Zingg, Daniel, et al.
Publicado: (2022)

Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas
por: Pu, Xiaohong, et al.
Publicado: (2023)

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene
Publicado: (1995)

The Expression of Tumor Rejection Antigen on Rat Fetus Fibroblasts Transformed by the ras Oncogene
por: Okubo, Mamoru, et al.
Publicado: (1988)

The Characterization of Cell Line Crl-2335 as a Basal-Like Breast Carcinoma Model
por: Hill Neves, Lori A., et al.
Publicado: (2011)

FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes
por: Furugaki, Koh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ua5qjpfn3actqn4dtcqdiejm0v